Literature DB >> 15452220

Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response.

Davide A Abate1, Shinya Watanabe, Edward S Mocarski.   

Abstract

We have identified a cytomegalovirus virion protein capable of modulating the rapid induction of an interferon-like response in cells that follows virus binding and penetration. Functional genomics revealed a role for the major cytomegalovirus structural protein, pp65 (ppUL83), in counteracting this response. The underlying mechanism involves a differential impact of this structural protein on the regulation of interferon response factor 3 (IRF-3). In contrast, NF-kappaB is activated independent of pp65, and neither STAT1 nor STAT3 becomes activated by either virus. pp65 is sufficient to prevent the activation of IRF-3 when introduced alone into cells. pp65 acts by inhibiting nuclear accumulation of IRF-3 and is associated with a reduced IRF-3 phosphorylation state. Thus, this investigation shows that the major structural protein of cytomegalovirus is committed to the modulation of the IRF-3 response, a primary mediator of the type I interferon response. By subverting IRF-3, the virus escapes throwing a central alarm devoted to both immediate antiviral control and regulation of the immune response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452220      PMCID: PMC521853          DOI: 10.1128/JVI.78.20.10995-11006.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  78 in total

1.  Significance analysis of microarrays applied to the ionizing radiation response.

Authors:  V G Tusher; R Tibshirani; G Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  Clonotypic structure of the human CD4+ memory T cell response to cytomegalovirus.

Authors:  A D Bitmansour; S L Waldrop; C J Pitcher; E Khatamzas; F Kern; V C Maino; L J Picker
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

Review 3.  Interferons alpha and beta as immune regulators--a new look.

Authors:  C A Biron
Journal:  Immunity       Date:  2001-06       Impact factor: 31.745

4.  A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation.

Authors:  A Skaletskaya; L M Bartle; T Chittenden; A L McCormick; E S Mocarski; V S Goldmacher
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

Review 5.  Viruses and interferons.

Authors:  G C Sen
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

6.  Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs.

Authors:  E P Browne; B Wing; D Coleman; T Shenk
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

7.  Requirement for uracil-DNA glycosylase during the transition to late-phase cytomegalovirus DNA replication.

Authors:  C T Courcelle; J Courcelle; M N Prichard; E S Mocarski
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

8.  Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B.

Authors:  K A Simmen; J Singh; B G Luukkonen; M Lopper; A Bittner; N E Miller; M R Jackson; T Compton; K Früh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

9.  Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling.

Authors:  R A Johnson; X Wang; X L Ma; S M Huong; E S Huang
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

10.  Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus.

Authors:  C M Preston; A N Harman; M J Nicholl
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

View more
  100 in total

1.  Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein.

Authors:  Ileana M Cristea; Nathaniel J Moorman; Scott S Terhune; Christian D Cuevas; Erin S O'Keefe; Michael P Rout; Brian T Chait; Thomas Shenk
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  New genes from old: redeployment of dUTPase by herpesviruses.

Authors:  Andrew J Davison; Nigel D Stow
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Sequence requirements for localization of human cytomegalovirus tegument protein pp28 to the virus assembly compartment and for assembly of infectious virus.

Authors:  Jun-Young Seo; William J Britt
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 and, consequently, inhibits beta interferon promoter activity.

Authors:  Kazima Saira; You Zhou; Clinton Jones
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

5.  Interferon regulatory factor 3 is necessary for induction of antiviral genes during human cytomegalovirus infection.

Authors:  Victor R DeFilippis; Bridget Robinson; Thomas M Keck; Scott G Hansen; Jay A Nelson; Klaus J Früh
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression.

Authors:  R Travis Taylor; Wade A Bresnahan
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  Guinea pig cytomegalovirus GP84 is a functional homolog of the human cytomegalovirus (HCMV) UL84 gene that can complement for the loss of UL84 in a chimeric HCMV.

Authors:  A McGregor; K Y Choi; M R Schleiss
Journal:  Virology       Date:  2010-11-20       Impact factor: 3.616

8.  UL26-deficient human cytomegalovirus produces virions with hypophosphorylated pp28 tegument protein that is unstable within newly infected cells.

Authors:  Joshua Munger; Dong Yu; Thomas Shenk
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

9.  Biologic and immunologic effects of knockout of human cytomegalovirus pp65 nuclear localization signal.

Authors:  John A Zaia; Xiuli Li; Anne E Franck; Xiwei Wu; Lia Thao; Ghislaine Gallez-Hawkins
Journal:  Clin Vaccine Immunol       Date:  2009-04-15

10.  An Attenuated CMV Vaccine with a Deletion in Tegument Protein GP83 (pp65 Homolog) Protects against Placental Infection and Improves Pregnancy Outcome in a Guinea Pig Challenge Model.

Authors:  Mark R Schleiss; Ryan Buus; K Yeon Choi; Alistair McGregor
Journal:  Future Virol       Date:  2013-12-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.